At 12 weeks, a combination pill containing candesartan cilexetil, amlodipine, and chlorthalidone improved BP in patients with hypertension.

Psychedelics have been studied for treating AUD, but supporting controlled trials are slim. There's much more substantial ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...

I am calling for Dr. Vinay Prasad to manage the FDA in a mature, professional, competent, transparent manner.  That’s just the bare minimum, and yet, he can’t even manage that.

Q3 2025 Earnings Call Transcript November 6, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-0.51282, expectations were $-2.15. Operator: Good day, and thank you for standing by.

As classrooms evolve into digital laboratories, artificial intelligence and simulation-based learning are preparing ...

Gilead Sciences (GILD) stock is in focus as the company fails in a late-stage trial which tested its Trodelvy cancer drug as a first-line therapy for breast cancer. Read more here.

ELATIVE long-term open label extension trial demonstrate sustained biochemical response, stabilization of fibrosis markers and consistent trends in improvement of fatigue and pruritus symptoms, ...

Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling Study for Cancer Interception in Lynch Syndrome Carriers New data from Phase ...